Hence, our study has uncovered a novel role for RSK2 in the DNA damage pathway and provided a link between CLS, a neurological disorder caused by mutated RSK2, and defects in the DNA damage response. Here, RPS6KA3 is linked to Coffin-Lowry syndrome.